CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER

CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER

Show other versions (1)

<p><strong>Aim.</strong> To study changes in prehospital pharmacotherapy with cardiovascular drugs in patients admitted to hospital with acute coronary syndrome (ACS) in 2005-2014.</p><p><strong>Material and methods.</strong> The data of the LIS register (Ly...

Full description

Bibliographic Details
Main Authors:	S. Y. Martsevich, M. L. Ginzburg, N. P. Kutishenko, A. V. Zagrebelnyy, I. S. Balashov, L. G. Garkina
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	острый коронарный синдром острый инфаркт миокарда регистр оценка догоспитальной лекарственной терапии
Online Access:	http://www.rpcardio.ru/jour/article/view/298

Similar Items

THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER)
by: M. L. Ginzburg, et al.
Published: (2015-09-01)

THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE
by: S. Y. Marcevich, et al.
Published: (2015-12-01)

EFFICACY AND SAFETY OF ACCELERATED DIAGNOSTIC PROTOCOL USE IN PATIENTS WITH SUSPECTED ACUTE CORONARY SYNDROME
by: O. V. Baturina, et al.
Published: (2015-09-01)

TRANSRADIAL ACCESS TO TREATMENT OF PATIENTS WITH ACS: STILL TRAINING OR ALREADY ROUTINE PRACTICE?
by: V V Majskov, et al.
Published: (2017-12-01)

IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME
by: R. G. Oganov, et al.
Published: (2015-12-01)

The estimation of risk factors of repeating myicardial infarction at patients with metabolic syndrome
by: Z I Mikashinowich, et al.
Published: (2010-09-01)

Outcomes of coronary artery bypass grafting in patients with high-risk non-ST-segment elevation acute coronary syndrome within the first 24 hours of admission
by: A. B. Nishonov, et al.
Published: (2020-07-01)

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID
by: N. F. Puchinyan, et al.
Published: (2016-01-01)

THE ANALYSIS OF FACTORS INFLUENCING THE TERMS OF HOSPITAL ADMISSION IN PATIENTS WITH ACUTE CORONARY SYNDROM (ACCORDING TO THE LIS STUDY DATA – LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION)
by: M. L. Ginzburg, et al.
Published: (2015-12-01)

ПРИМЕНЕНИЕ ЛЕВОСИМЕНДАНА В ПЕРИОПЕРАЦИОННОМ ПЕРИОДЕ У БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ ПРИ АОРТОКОРОНАРНОМ ШУНТИРОВАНИИ
by: B. М. Тоdurov, et al.
Published: (2017-12-01)

Thrombolytic therapy and cardiac free wall rupture in patients with acute myocardial infarction
by: E M Zeltyn-Abramov, et al.
Published: (2009-03-01)

Prospective study one-year clinical outcomes of the Calypso coronary stent in patients presenting with acute coronary syndrome
by: В. Л. Воробьев, et al.
Published: (2017-04-01)

IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY
by: O. V. Reshetko, et al.
Published: (2016-01-01)

SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)

MYOCARDIAL REVASCULARIZATION IN ACUTE CORONARY SYNDROME IN UDMURT REPUBLIC
by: Natalya Mikhailovna Kuzmina
Published: (2017-10-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

EFFECT OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION ON CEREBRAL HEMODYNAMICS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (THE RESULTS OF OBSERVATIONAL STUDIES)
by: V. E. Kulikov, et al.
Published: (2015-12-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME
by: O. V. Reshetko, et al.
Published: (2015-12-01)

ABOUT SOME MISTAKES AND REASONS FOR THEM IN ACUTE CORONARY SYNDROME TREATMENT
by: G. I. Zimarin, et al.
Published: (2015-12-01)

Estimation of water homeostasis parameters at patients with cardiovascular diseases
by: Z I Mikashinowich, et al.
Published: (2009-12-01)

ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER)
by: Yu. V. Lukina, et al.
Published: (2015-09-01)

КЛИНИЧЕСКИЙ СЛУЧАЙ АЛЛЕРГИЧЕСКОГО ОСТРОГО КОРОНАРНОГО СИНДРОМА (СИНДРОМА КОУНИСА), ВЫЗВАННОГО ХОЛОДОВОЙ КРАПИВНИЦЕЙ
by: L. V. Kalatsei, et al.
Published: (2021-05-01)

Development of a risk score for no-reflow phenomenon after percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction
by: I. S. Bessonov, et al.
Published: (2020-11-01)

Сравнительный клинико-экономический анализ применения тромболитиков Фортелизин® и Актилизе® у пациентов с острым инфарктом миокарда
Published: (2018-06-01)

CLOPIDROGEL – HISTORIC AND MODERN BASIS OF ANTI-PLATELET THERAPY OF ACS
by: S. K. ZYRYANOV, et al.
Published: (2016-12-01)

Results bivalirudin use in actual practice in patients with acute coronary syndrome during percutaneous coronary intervention
by: Z H Shugushev, et al.
Published: (2014-12-01)

Энергетическая оценка влияния левосимендана на кислородный бюджет при экстренном аортокоронарном шунтировании у больных с острым коронарным синдромом
by: К. G. Мikhnevych, et al.
Published: (2018-02-01)

Clinical and instrumental predictors of upcoming cardiac free wall rupture due to acute miocardial infarction
by: E M Zeltyn-Abramov, et al.
Published: (2008-06-01)

Фармакоэпидемиология острого коронарного синдрома. Отечественный анализ реальной практики назначений
Published: (2018-06-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Клопидогрель и предотвращение тромботических осложнений атеросклероза: стоимость таблеток или эффективность затрат?
Published: (2018-06-01)

Endovascular treatment of acute coronary syndrome in patients with chronic obstructive pulmonary disease
by: А. М. Намитоков, et al.
Published: (2015-10-01)

Сравнительный экономический анализ клопидогрела и тикагрелора при остром коронарном синдроме
Published: (2018-06-01)

Thrombus aspiration catheter in acute coronary occlusions
by: M Yu Movsesyants, et al.
Published: (2010-03-01)

FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY
by: O. G. Zaylobidinov, et al.
Published: (2016-01-01)

APPROACHES TO INCREASE THE AVAILABILITY AND EFFECTIVENESS OF PRE-HOSPITAL THROMBOLYSIS IN REAL CLINICAL PRACTICE
by: L. A. Ostroumova, et al.
Published: (2015-12-01)